|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of revenues ($223, $140 and $125 to a related party) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Gain from sale of assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income, net | |||||
| Gain on change in fair value of warrant liability | |||||
| Issuance costs associated with warrant liability | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares used in per share calculations: | |||||
| Basic | |||||
| Diluted |
Loading...